HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
December 18, 2024
12:00 PM - 01:30 PM ET
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs
ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC
Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC
Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies
Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies
